NI
ITCI

Numeric Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Numeric Investors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-83,900
Closed -$1.32M – 1207
2017
Q3 		$1.32M Sell
83,900
-129,500
-61% -$1.9M 0.01% 693
2017
Q2 		$2.65M Sell
213,400
-111,800
-34% -$1.3M 0.02% 453
2017
Q1 		$5.28M Buy
325,200
+257,291
+379% +$3.72M 0.05% 315
2016
Q4 		$1.02M Buy
+67,909
New +$959K 0.01% 657
2015
Q3 		– Sell
-26,100
Closed -$834K – 1181
2015
Q2 		$834K Buy
+26,100
New +$662K 0.01% 532

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Numeric Investors's ITCI Position: Q4 2017 in Review

Numeric Investors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2017, closing a stake of 83,900 shares — an estimated $1.32M sold.

Numeric Investors first reported a position in ITCI in Q2 2015 and held it in 5 quarters. The position peaked at $5.28M in Q1 2017. 131 funds tracked by Wall St. Rank hold ITCI as of Q4 2017.

  • Numeric Investors reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2017 after selling out during the quarter.
  • Numeric Investors sold 83,900 Intra-Cellular Therapies Inc. shares in Q4 2017, an estimated $1.32M.
  • Numeric Investors first reported a position in Intra-Cellular Therapies Inc. in Q2 2015 and held it in 5 quarters.
  • Numeric Investors's Intra-Cellular Therapies Inc. position peaked at $5.28M in Q1 2017.
  • 131 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.